News
-
Resolution of 7th International Award for Contribution to Chinese Medicine—Achievement in Chinese Medicine Standardization
In order to reward the outstanding standard items that have great contribution in the international standardization activities on Chinese medicine, the 7thInternational Award for Contribution to Chinese Medicine—Achievement in Chinese Medicine Standardization has been launched for the first in 2022. According to the Incentive Scheme for the International Award for Contribution to Chinese Medicine, World Federation of Chinese Medicine Societies (WFCMS) organized detailed award review process.Nov 29,2022 -
Resolution on Granting the 7th International Award for Contribution to Chinese Medicine
In order to honor the prominent groups and individuals who make great contribution to the promotion of international spread and development of TCM, and to encourage the initiative and creativity of global entities and professionals in TCM, we organized the appraisal progress for the 7th International Award for Contribution to Chinese Medicine according to “the Incentive Scheme for the International Award for Contribution to Chinese Medicine, WFCMS”.Nov 29,2022 -
Onset and Recurrence Characteristics of Chinese Patients with Noncardiogenic Ischemic Stroke in Chinese Medicine Hospitals
Objective:To delineate the onset and recurrence characteristics of noncardiogenic ischemic stroke patients in China.Sept 29,2022 -
Efficacy and safety of external application of Chinese herbal medicine trials
OBJECTIVE:To evaluate the clinical efficacy and safety of external application of Chinese herbal medicine（exCHM） for psoriasis vulgaris（PV）.Sept 29,2022 -
DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B
Objective:To explore the molecular bases of Chinese medicine（CM） syndrome classification in chronic hepatitis B（CHB） patients in terms of DNA methylation,transcription and cytokines.Sept 29,2022 -
Common traditional Chinese medicine therapies for diarrhea-predominant irritable bowel syndrome: An overview of systematic reviews
Objective: To critically evaluate and summarize the methodological quality of systematic reviews（SRs）and present objective and important outcomes on the effectiveness of traditional Chinese medicine（TCM） therapies, including Chinese herbal medicine（CHM）, acupuncture, and moxibustion, for diarrheapredominant irritable bowel syndrome（IBS-D）.Sept 28,2022
